More Potential Overview
Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.
Search
Anti-fibrotic agent
Anti-fibrotic agent
100-year anniversary of BI in respiratory care
100-year anniversary of Boehringer Ingelheim in respiratory care
Cardio-Renal-Metabolic Infographic Update 2023
Partnering in Cardiometabolic Diseases MAY 2023 Corp
Partnering_In_CARDIOMETABOLIC_0.pdf
Partnering in Cardiometabolic JAN 2023
Partnering in Cardiometabolic JAN 2023 Corporate
Cardiovascular renal and metabolic diseases infographic
cardiometabolic_retinal_partner_interests.pdf
CardioMetabolic_diseases.pdf
CardioMetabolic_infographic_FINAL Dec 18 V2.pdf
cardiometabolic_flyer_bio_2019.pdf
CardioMetabolic_Partnering_Interests_2018-12.pdf
Cardiometabolic_Diseases.pdf
CardioMetabolic_infographic_Update_2021.pdf
CardioMetabolic_Flyer_BIO_2022.pdf
Animal Health Partnering Interests Cardiometabolic Diseases May 2024 CORP
Partnering in Cardiometabolic Diseases MAY 2024 CORP_0.pdf
Partnering in Cardio-Renal-Metabolic MAY 2024 CORP .pdf
Discover your hidden talent with BI Open – the new platform for data science enthusiasts
Discover your hidden talent with BI Open – the new platform for data science enthusiasts. For more talent insights, visit our Careers Page.
NPY2r agonist
Food intake regulator
Avenciguat (BI 685509)
Avenciguat (BI 685509)
Catherine Alonzo
Catherine Alonzo, Patient Safety Physician, Metabolism, tells us about the importance of drug surveillance.
BI 765845
Heart disease modulator